Ladányi, A.; Rásó, E.; Barbai, T.; VÃzkeleti, L.; Puskás, L.G.; Kovács, S.A.; GyÅ‘rffy, B.; TÃmár, J.
Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy. Int. J. Mol. Sci. 2022, 23, 2704.
https://doi.org/10.3390/ijms23052704
AMA Style
Ladányi A, Rásó E, Barbai T, VÃzkeleti L, Puskás LG, Kovács SA, GyÅ‘rffy B, TÃmár J.
Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy. International Journal of Molecular Sciences. 2022; 23(5):2704.
https://doi.org/10.3390/ijms23052704
Chicago/Turabian Style
Ladányi, Andrea, Erzsébet Rásó, Tamás Barbai, Laura VÃzkeleti, László G. Puskás, Szonja A. Kovács, Balázs GyÅ‘rffy, and József TÃmár.
2022. "Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy" International Journal of Molecular Sciences 23, no. 5: 2704.
https://doi.org/10.3390/ijms23052704
APA Style
Ladányi, A., Rásó, E., Barbai, T., VÃzkeleti, L., Puskás, L. G., Kovács, S. A., GyÅ‘rffy, B., & TÃmár, J.
(2022). Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy. International Journal of Molecular Sciences, 23(5), 2704.
https://doi.org/10.3390/ijms23052704